Status
Conditions
Treatments
About
Vagus nerve stimulation (VNS) is an adjunctive treatment for refractory epilepsy. Although widely used, there is still a substantial number of patients with insufficient response. Light, and particularly blue light, can stimulate alertness, attention and cognition through modulation of anatomical targets which are common to the vagal afferent network. This project aims at understanding how exposure to blue enriched light may influence VNS effects in patients with refractory epilepsy by exploring the modulation of a series of biomarkers of VNS action. This could possibly lead to new therapeutic strategies to increase efficacy of VNS.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients:
VNS implanted since at least 3 months age >18-60 years; IQ >55 on Wechsler scale (normal status or mild cognitive impairment)
healthy participants aged between 18 and 35 years without any medical history (neurological / psychiatric disease)
Exclusion criteria
Patients:
other medical implanted devices than VNS, ocular diseases
Helthy participants:
medical implanted devices, cerebral trauma, ocular disease
Primary purpose
Allocation
Interventional model
Masking
34 participants in 2 patient groups
Loading...
Central trial contact
Inci cakiroglu
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal